Literature DB >> 7142467

Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.

L A Lee, K A Fritz, L Golitz, T J Fritz, W L Weston.   

Abstract

Previous reports of skin cancer occurring in mycosis fungoides patients who have been treated with topical nitrogen mustard have been of carcinomas occurring predominantly on sun-exposed skin. Four of twenty-nine mycosis fungoides patients in our clinic treated with topical nitrogen mustard developed six skin cancers on sun-protected skin. Four lesions were squamous cell carcinomas and two were basal cell carcinomas. Few other risk factors for the development of skin cancer were present in our patients. These cases support the hypothesis that topical nitrogen mustard is a carcinogen or tumor promote and emphasize the need for careful examination of the skin of patients treated with topical nitrogen mustard.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7142467     DOI: 10.1016/s0190-9622(82)70138-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Long term follow up of topical mustine treatment for cutaneous langerhans cell histiocytosis.

Authors:  P H Hoeger; V R Nanduri; J I Harper; D A Atherton; J Pritchard
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

2.  Strategies for treating cutaneous T-cell lymphoma: part 1: remission.

Authors:  Jo-Ann Latkowski; Peter Heald
Journal:  J Clin Aesthet Dermatol       Date:  2009-06

3.  Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial.

Authors:  Joselin D Tacastacas; Derek V Chan; Sean Carlson; Stanton L Gerson; Afshin Dowlati; Pingfu Fu; Kurt Lu; Sarah Groft; Julie Rosenjack; Kord Honda; Thomas S McCormick; Kevin D Cooper
Journal:  JAMA Dermatol       Date:  2017-05-01       Impact factor: 10.282

Review 4.  Squamous cell carcinoma of the scrotum: A look beyond the chimneystacks.

Authors:  Ritva Vyas; Homayoun Zargar; Rossella Di Trolio; Giuseppe Di Lorenzo; Riccardo Autorino
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.